No Data
The Nikkei Average is about 270 yen higher, continuing to show stable price movements supported by the rise in US stocks = the morning session of the 26th.
On the morning of the 26th, the Nikkei average Stock price fluctuated around 38,050 yen, up about 270 yen from the previous day. At 9:42 AM, it rose to 38,151.39 yen, up 370.85 yen, once again surpassing 38,000 yen. On the 25th local time, the US Stock market saw both the Dow Inc and the Nasdaq Composite Index rise for three consecutive days. Concerns about the US economy due to mutual tariffs have eased, supporting stock prices. The Tokyo market also seems to have seen buying activity in response to the rise in US stocks. The yen-denominated settlement value of the Chicago Nikkei average Futures.
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○List of stocks for Buy conversion Market Code Stock Name Closing Price SAR Main Board <1949> Sumitomo Electric Industries 4500 4115 <1976> Meisei Industry 12271192 <2120> LIFULL 165157 <2220> Kameda Seika 40003850 <2222> Kotobuki Spirits 23532281 <2395> Shin Nikko Science 15171386 <2585> Life Drink C 15751398 <2
INPEX, Haseko etc. (additional) Rating
Upgrades - Bullish Code Stock Name Securities Company Previous After ----------------------------------------------------------- <1979> Taiki SMBC Nikko "2" "1" <4887> Sawai GHD Nomura "Neutral" "Buy" <5706> Mitsui Gold Daiwa "3" "2" <9508> Kyushu Electric Nomura "Neutral" "Buy" Downgrades - Bearish Code Stock Name Securities Company Previous After --------
Rating information (Target Price change - part 2) = SUMCO, Chugai Pharmaceutical, ETC.
◎ Mizuho Securities (three levels: Buy > Hold > underperform) SUMCO <3436.T> -- "Buy" → "Buy", 2300 yen → 2100 yen UBE <4208.T> -- "Buy" → "Buy", 3600 yen → 3000 yen M3 <2413.T> -- "Hold" → "Hold", 1600 yen → 1900 yen ◎ Morgan Stanley MUFG Securities (three levels: Overweight > Equal Weight > Underweight) Chugai Pharmaceutical <4519.T> -- "Overweight"
JMDC Inc. Transfers NOAH MEDICAL to KAKEHASHI for Strategic Growth
JMDC: Extraordinary Report